Top Markets
Coin of the day
Sinew Pharma Inc. Sinew Pharma Inc.

Sinew Pharma Inc.

6634
주식 순위 #20222
Sinew Pharma Inc. is a biopharmaceutical enterprise dedicated to the research,... Sinew Pharma Inc. is a biopharmaceutical enterprise dedicated to the research, development, and commercialization of new therapeutics. Its core mission revolves around pioneering innovative solutions for hepatotoxicity-free acetaminophen and addressing various fatty liver conditions. The company's robust pipeline features SNP-610, a drug candidate currently advancing through Phase II clinical trials in Taiwan for the treatment of non-alcoholic steatohepatitis (NASH). Another early-stage compound, SNP-630, is also in preclinical development, targeting NASH. Beyond liver disease, Sinew Pharma is progressing SNP-810 for its analgesic and antipyretic properties. Furthermore, the firm is developing SNP-830 and SNP-840, positioned as liver-safe pain medications specifically for the United States market. Established in 2014, Sinew Pharma Inc. maintains its headquarters in Taipei City, Taiwan.
주가
$1.91
시가총액
$136.47M
변동 (1일)
-1.15%
변동 (1년)
21.17%
국가
TW
거래 Sinew Pharma Inc. (6634)

카테고리

Sinew Pharma Inc. (6634)의 주가 이력
최고 종가: $1.89 (2026-08-01 기준)

최저 종가: $1.60 (2017-06-01 기준)
Sinew Pharma Inc.의 주가 이력 (2017 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) 19.74%
2025 -14.90%
2024 -33.41%
2023 -38.58%
2022 20.56%
2021 26.00%
2020 195.09%
2019 88.41%
2018 -46.85%
2017 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$547.80 38.64%
US
$1.01K 53.55%
NL
$119.27 -15.19%
AU
$766.03 8.39%
CH
$132.57 388.82%
US